BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1304450)

  • 1. Heart in pituitary diseases.
    Hradec J; Marek J; Král J; Simper D; Spácil J
    Cor Vasa; 1992; 34(2):101-7. PubMed ID: 1304450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart disease in acromegaly. Study of 27 patients].
    Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F
    Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiological findings in acromegaly].
    Ferramosca B; Bianchi D; Serra D; Savini R; Villecco AS; Bugiardini R
    Minerva Med; 1987 Dec; 78(24):1813-21. PubMed ID: 3431727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and the cardiovascular function.
    Svensson J; Tivesten A; Isgaard J
    Minerva Endocrinol; 2005 Mar; 30(1):1-13. PubMed ID: 15877009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heart in acromegaly: correlation of echocardiographic and clinical findings.
    Luboshitzki R; Hammerman H; Barzilai D; Markiewicz W
    Isr J Med Sci; 1980 May; 16(5):378-83. PubMed ID: 6447120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard electrocardiography and Holter monitoring changes in acromegalic patients].
    Twardowski R; Dabek J; Jakubowski D; Gasior Z
    Pol Merkur Lekarski; 2007 Jun; 22(132):519-23. PubMed ID: 17874620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac effects of GH].
    Fazio S; Sabatini D; Cittadini A; Santomauro M; Merola B; Biondi B; Colao A; Lombardi G; Saccà L
    Minerva Endocrinol; 1993 Sep; 18(3 Suppl 1):69-75. PubMed ID: 8190051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart disease in acromegaly.
    Hradec J; Král J; Janota T; Marek J
    Sb Lek; 1995; 96(4):433-5. PubMed ID: 8711397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The heart: an end-organ of GH action.
    Colao A; Vitale G; Pivonello R; Ciccarelli A; Di Somma C; Lombardi G
    Eur J Endocrinol; 2004 Aug; 151 Suppl 1():S93-101. PubMed ID: 15339252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late potentials and ventricular arrhythmias in acromegaly.
    Maffei P; Martini C; Milanesi A; Corfini A; Mioni R; de Carlo E; Menegazzo C; Scanarini M; Vettor R; Federspil G; Sicolo N
    Int J Cardiol; 2005 Sep; 104(2):197-203. PubMed ID: 16168814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion abnormalities in patients with active acromegaly.
    Herrmann BL; Brandt-Mainz K; Saller B; Bruch C; Wieneke H; Kügler C; Ferdin S; Hahn S; Erbel R; Bockisch A; Mann K
    Horm Metab Res; 2003 Mar; 35(3):183-8. PubMed ID: 12734780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature of cardiac hypertrophy in acromegaly: an echocardiographic study.
    Hradec J; Marek J; Petrásek J
    Cor Vasa; 1988; 30(3):186-99. PubMed ID: 3168477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.